Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

SIMPLE SUMMARY: Recently, the introduction of immunotherapy radically changed the therapeutic algorithm of non-small-cell lung cancer as an upfront or secondary strategy. Unfortunately, the small amount of patient benefits from immune-checkpoint inhibitors (ICI) and the prognostic role of concomitan...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giglio, Andrea, Mezquita, Laura, Auclin, Edouard, Blanc-Durand, Félix, Riudavets, Mariona, Caramella, Caroline, Martinez, Gala, Benitez, Jose Carlos, Martín-Romano, Patricia, El-Amarti, Lamiae, Hendriks, Lizza, Ferrara, Roberto, Naltet, Charles, Lavaud, Pernelle, Gazzah, Anas, Adam, Julien, Planchard, David, Chaput, Nathalie, Besse, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599488/
https://www.ncbi.nlm.nih.gov/pubmed/33007977
http://dx.doi.org/10.3390/cancers12102827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599488/
https://www.ncbi.nlm.nih.gov/pubmed/33007977
http://dx.doi.org/10.3390/cancers12102827

Ejemplares similares